language_icon
EN
HI

Solara Active Pharma Sciences Share price

SOLARA

579.9

72.20 (14.22%)
NSE
BSE
Last updated on 15 May, 2026 | 15:51 IST
Today's High

598.50

Today's Low

502.00

52 Week Low

422.00

52 Week High

734.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Solara Active Pharma Sciences Chart

Solara Active Pharma Sciences Share Key Metrics

Volume
40.14 L
Market Cap
2097.66 CR
LTQ@LTP
9@579.90
ATP
575.83
Var Margin
21.67 %
Circuit Range
406.2-609.2
Delivery %
37.41 %
Value
231.12 CR
ASM/GSM
No
Market Lot
1

Summary

Solara Active Pharma Sciences share price is ₹579.9 as of 17 May, 2026. The stock Solara Active Pharma Sciences intraday movement has stayed between ₹502.00 and ₹598.50, while on a 52-week basis,Solara Active Pharma Sciences price 52 week high is ₹734.40 & its 52 week low is ₹422.00.
In terms of trading activity, Solara Active Pharma Sciences has recorded a volume of 4013707 shares, The Solara Active Pharma Sciences has a market cap of ₹36172807 CR. The stock’s Average Traded Price (ATP) stands at ₹575.83, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹579.90.
Solara Active Pharma Sciences operates within a circuit range of ₹406.20 – ₹609.20, with a Value of ₹231.12 CR. The Delivery Percentage for the day is 37.41%. Additionally, Solara Active Pharma Sciences currently falls under the No framework, and trades with a market lot size of 1.

Solara Active Pharma Sciences Fundamentals

View More
P/E Ratio

0

P/B Ratio

2.25

Div. Yield

0

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Solara Active Pharma Sciences Resistance and Support

Pivot 504.33

Resistance

First Resistance

516.46

Second Resistance

525.23

Third Resistance

537.36

Support

First Support

495.56

Second Support

483.43

Third Support

474.66

Solara Active Pharma Sciences Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

42%

Mutual Fund

1.18%

Insurance

0%

Foreign Institutional Investors

11.59%

Domestic Institutional Investors

2.57%

Retail

42.66%

Others

0%

Total Promoters
MAR '26
42%

Solara Active Pharma Sciences Corporate Actions

DateAgenda
2026-05-15Audited Results
2026-03-24Others
2026-02-06Quarterly Results
2025-11-05Quarterly Results
2025-07-25Quarterly Results
2025-05-15Audited Results
2025-04-02Others
2025-03-26Rights Issue & Others
2025-01-24Quarterly Results

Solara Active Pharma Sciences News

Solara Active Pharma Sciences Ltd - 541540 - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended March 31, 2026.

Solara Active Pharma Sciences announced no deviation in the utilization of Rs. 309.79 crore funds raised through its Rights Issue for the quarter ended March 31, 2026. The Audit Committee reviewed and approved the statement, confirming Rs. 233.61 crore was utilized.
May 15 2026 14:05:00

Solara Active Pharma Sciences Ltd - 541540 - Intimation In Relation To The Rights Issue

Solara Active Pharma Sciences received Rs.129.94 crore from the second and final call on its rights equity shares. This conversion affects 1.15 crore partly paid shares to fully paid status, strengthening the company's capital structure.
May 15 2026 14:05:00

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Solara Active Pharma Sciences reported strong Q4 FY26 results with a PAT of Rs.9.6 cr, marking a turnaround to profitability and achieving its highest revenue, gross margin, and EBITDA in eight quarters. The board is also evaluating strategic options for its Ibuprofen business.
May 15 2026 13:05:00

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Year Ended March 31, 2026 And Unaudited Financial Results For The Quarter Ended March 31, 2026.

Solara Active Pharma Sciences board approved Q4 FY26 consolidated net profit of ₹9.60 cr and FY26 consolidated net loss of ₹7.41 cr. The company reported accumulated losses of ₹319.33 cr and net current liabilities exceeding net current assets by ₹35.81 cr, with the board approving results on a going concern basis.
May 15 2026 13:05:00

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Solara Active Pharma Sciences has announced an investor conference call on May 15, 2026, at 3:00 PM IST to discuss its audited financial results for Q4 FY26. This call will provide an opportunity for analysts and investors to engage with management regarding the company's performance.
May 11 2026 16:05:00

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('Listing Regulations')

Solara Active Pharma Sciences will hold a board meeting on May 15, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
May 08 2026 21:05:00

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Solara Active Pharma Sciences successfully closed the US FDA inspection for its Puducherry manufacturing facility. The inspection was classified as Voluntary Action Indicated (VAI), ensuring continued cGMP compliance for the Ibuprofen plant.
Apr 28 2026 17:04:00

Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences announced the successful closure of its Puducherry facility's US FDA inspection, which was classified as 'Voluntary Action Indicated (VAI)'. This outcome demonstrates the company's commitment to quality and regulatory compliance for its Ibuprofen manufacturing unit.
Apr 28 2026 17:04:00
Read More

About Solara Active Pharma Sciences

NSE : 3672  
BSE : 541540  
ISIN : INE624Z01016  

Solara Active Pharma Sciences Management

NamePosition
Pooja Jaya KumarCompany Secretary & Compliance Officer
R RamakrishnanChairman
View More

Solara Active Pharma Sciences FAQs

The Buying Price of Solara Active Pharma Sciences share is 579.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Solara Active Pharma Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Solara Active Pharma Sciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Solara Active Pharma Sciences shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Solara Active Pharma Sciences shares is 2.25. Useful to assess the stock's value relative to its book value.

To assess Solara Active Pharma Sciences’s valuation compare Sector P/E, P/B which are 71.32 & 3.47 with sector averages, along with growth rates and financial metrics.

The Market Cap of Solara Active Pharma Sciences is 2097.66 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Solara Active Pharma Sciences share price is 734.40 & 422.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Solara Active Pharma Sciences belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost